These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16729195)

  • 1. Manifold decrease of sialic acid synthase in fetal Down syndrome brain.
    Gulesserian T; Engidawork E; Fountoulakis M; Lubec G
    Amino Acids; 2007 Jan; 32(1):141-4. PubMed ID: 16729195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of signaling-related proteins 14-3-3 gamma and RACK1 in fetal Down syndrome brain (trisomy 21).
    Peyrl A; Weitzdoerfer R; Gulesserian T; Fountoulakis M; Lubec G
    Electrophoresis; 2002 Jan; 23(1):152-7. PubMed ID: 11824616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manifold reduction of moesin in fetal Down syndrome brain.
    Lubec B; Weitzdoerfer R; Fountoulakis M
    Biochem Biophys Res Commun; 2001 Sep; 286(5):1191-4. PubMed ID: 11527426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deranged hypothetical proteins Rik protein, Nit protein 2 and mitochondrial inner membrane protein, Mitofilin, in fetal Down syndrome brain.
    Myung J; Gulesserian T; Fountoulakis M; Lubec G
    Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):739-46. PubMed ID: 14528910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased brain levels of Lupus La protein and increased U5 small ribonucleoprotein-specific 40 kDa protein in fetal Down syndrome.
    Gulesserian T; Engidawork E; Fountoulakis M; Lubec G
    Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):733-8. PubMed ID: 14528909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced cell number in the neocortical part of the human fetal brain in Down syndrome.
    Larsen KB; Laursen H; Graem N; Samuelsen GB; Bogdanovic N; Pakkenberg B
    Ann Anat; 2008 Nov; 190(5):421-7. PubMed ID: 18722098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic evaluation of intermediary metabolism enzyme proteins in fetal Down's syndrome cerebral cortex.
    Bajo M; Fruehauf J; Kim SH; Fountoulakis M; Lubec G
    Proteomics; 2002 Nov; 2(11):1539-46. PubMed ID: 12442254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma.
    Kolialexi A; Tsangaris GT; Papantoniou N; Anagnostopoulos AK; Vougas K; Bagiokos V; Antsaklis A; Mavrou A
    Prenat Diagn; 2008 Aug; 28(8):691-8. PubMed ID: 18551720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers.
    Nagalla SR; Canick JA; Jacob T; Schneider KA; Reddy AP; Thomas A; Dasari S; Lu X; Lapidus JA; Lambert-Messerlian GM; Gravett MG; Roberts CT; Luthy D; Malone FD; D'Alton ME
    J Proteome Res; 2007 Apr; 6(4):1245-57. PubMed ID: 17373838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression of centractin and capping proteins, integral constituents of the dynactin complex, in fetal down syndrome brain.
    Gulesserian T; Kim SH; Fountoulakis M; Lubec G
    Biochem Biophys Res Commun; 2002 Feb; 291(1):62-7. PubMed ID: 11829462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystathionine beta-synthase is enriched in the brains of Down's patients.
    Ichinohe A; Kanaumi T; Takashima S; Enokido Y; Nagai Y; Kimura H
    Biochem Biophys Res Commun; 2005 Dec; 338(3):1547-50. PubMed ID: 16274669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein expression of BACE1, BACE2 and APP in Down syndrome brains.
    Cheon MS; Dierssen M; Kim SH; Lubec G
    Amino Acids; 2008 Aug; 35(2):339-43. PubMed ID: 18163181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part II).
    Cheon MS; Bajo M; Kim SH; Claudio JO; Stewart AK; Patterson D; Kruger WD; Kondoh H; Lubec G
    Amino Acids; 2003; 24(1-2):119-25. PubMed ID: 12624743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal Down syndrome brains exhibit aberrant levels of neurotransmitters critical for normal brain development.
    Whittle N; Sartori SB; Dierssen M; Lubec G; Singewald N
    Pediatrics; 2007 Dec; 120(6):e1465-71. PubMed ID: 17998315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of C1-tetrahydrofolate synthase in fetal Down syndrome brain.
    Fountoulakis M; Gulesserian T; Lubec G
    J Neural Transm Suppl; 2003; (67):85-93. PubMed ID: 15068241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways.
    Rachidi M; Lopes C
    Eur J Paediatr Neurol; 2008 May; 12(3):168-82. PubMed ID: 17933568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manifold decreased protein levels of matrin 3, reduced motor protein HMP and hlark in fetal Down's syndrome brain.
    Bernert G; Fountoulakis M; Lubec G
    Proteomics; 2002 Dec; 2(12):1752-7. PubMed ID: 12469345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enzymes of sialic acid biosynthesis.
    Tanner ME
    Bioorg Chem; 2005 Jun; 33(3):216-28. PubMed ID: 15888312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling in the adult Down syndrome brain.
    Lockstone HE; Harris LW; Swatton JE; Wayland MT; Holland AJ; Bahn S
    Genomics; 2007 Dec; 90(6):647-60. PubMed ID: 17950572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Derangement of hypothetical proteins in fetal Down's syndrome brain.
    Shin JH; Gulesserian T; Weitzdoerfer R; Fountoulakis M; Lubec G
    Neurochem Res; 2004 Jun; 29(6):1307-16. PubMed ID: 15176487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.